Tran-Duy A - Search Results

1

Use of Proton Pump Inhibitors and Risks of Fundic Gland Polyps and Gastric Cancer: Systematic Review and Meta-analysis.

Tran-Duy A, Spaetgens B, Hoes AW, de Wit NJ, Stehouwer CD. Tran-Duy A, et al. Clin Gastroenterol Hepatol. 2016 Dec;14(12):1706-1719.e5. doi: 10.1016/j.cgh.2016.05.018. Epub 2016 May 20. Clin Gastroenterol Hepatol. 2016. PMID: 27211501 Review.

2

Reply.

Tran-Duy A, Spaetgens B, Hoes AW, de Wit NJ, Stehouwer CDA. Tran-Duy A, et al. Clin Gastroenterol Hepatol. 2017 May;15(5):790. doi: 10.1016/j.cgh.2017.01.008. Epub 2017 Jan 20. Clin Gastroenterol Hepatol. 2017. PMID: 28115211 No abstract available.

3

Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study.

Tran-Duy A, Connell NJ, Vanmolkot FH, Souverein PC, de Wit NJ, Stehouwer CDA, Hoes AW, de Vries F, de Boer A. Tran-Duy A, et al. J Intern Med. 2019 Feb;285(2):205-214. doi: 10.1111/joim.12826. Epub 2018 Sep 17. J Intern Med. 2019. PMID: 30141278 Free article.

4

Should patients prescribed long-term low-dose aspirin receive proton pump inhibitors? A systematic review and meta-analysis.

Tran-Duy A, Vanmolkot FH, Joore MA, Hoes AW, Stehouwer CD. Tran-Duy A, et al. Int J Clin Pract. 2015 Oct;69(10):1088-111. doi: 10.1111/ijcp.12634. Epub 2015 Apr 6. Int J Clin Pract. 2015. PMID: 25846476 Review.

5

Health and Utilities in Patients With Gout Under the Care of a Rheumatologist.

Spaetgens B, Tran-Duy A, Wijnands JM, van der Linden S, Boonen A. Spaetgens B, et al. Arthritis Care Res (Hoboken). 2015 Aug;67(8):1128-36. doi: 10.1002/acr.22551. Arthritis Care Res (Hoboken). 2015. PMID: 25604934 Free article.

6

Construct Validity of Radiographs of the Feet to Assess Joint Damage in Patients with Gout.

Spaetgens B, van Durme C, Webers C, Tran-Duy A, Schoonbrood T, Boonen A. Spaetgens B, et al. J Rheumatol. 2017 Jan;44(1):91-94. doi: 10.3899/jrheum.160737. Epub 2016 Dec 1. J Rheumatol. 2017. PMID: 27909088

7

Modelling outcomes of complex treatment strategies following a clinical guideline for treatment decisions in patients with rheumatoid arthritis.

Tran-Duy A, Boonen A, Kievit W, van Riel PL, van de Laar MA, Severens JL. Tran-Duy A, et al. Pharmacoeconomics. 2014 Oct;32(10):1015-28. doi: 10.1007/s40273-014-0184-4. Pharmacoeconomics. 2014. PMID: 24972589

8

A discrete event modelling framework for simulation of long-term outcomes of sequential treatment strategies for ankylosing spondylitis.

Tran-Duy A, Boonen A, van de Laar MA, Franke AC, Severens JL. Tran-Duy A, et al. Ann Rheum Dis. 2011 Dec;70(12):2111-8. doi: 10.1136/annrheumdis-2011-200333. Epub 2011 Aug 20. Ann Rheum Dis. 2011. PMID: 21857027

9

Impact on total population health and societal cost, and the implication on the actual cost-effectiveness of including tumour necrosis factor-α antagonists in management of ankylosing spondylitis: a dynamic population modelling study.

Tran-Duy A, Boonen A, van de Laar MA, Severens JL. Tran-Duy A, et al. Cost Eff Resour Alloc. 2015 Oct 7;13:18. doi: 10.1186/s12962-015-0044-x. eCollection 2015. Cost Eff Resour Alloc. 2015. PMID: 26451133 Free PMC article.

10

Early cost-utility analysis of general and cerebrospinal fluid-specific Alzheimer's disease biomarkers for hypothetical disease-modifying treatment decision in mild cognitive impairment.

Handels RL, Joore MA, Tran-Duy A, Wimo A, Wolfs CA, Verhey FR, Severens JL. Handels RL, et al. Alzheimers Dement. 2015 Aug;11(8):896-905. doi: 10.1016/j.jalz.2015.02.009. Epub 2015 Jun 9. Alzheimers Dement. 2015. PMID: 26071009 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page